share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144：擬議出售證券
美股sec公告 ·  05/03 03:30
牛牛AI助理已提取核心訊息
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,016 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market price of $43,828, were acquired on 05/01/2024 through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a previous sale of 3,760 shares by Matsuda in the past three months, which had gross proceeds of $41,815.
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,016 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market price of $43,828, were acquired on 05/01/2024 through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a previous sale of 3,760 shares by Matsuda in the past three months, which had gross proceeds of $41,815.
根據最新文件，Arcutis Biotherapeutics, Inc.高管松田正定於2024年2月5日出售5,016股普通股。這些股票的總市價爲43,828美元，於2024年1月5日通過Arcutis Biotherapeutics的限制性股票背心收購。該交易是在松田在過去三個月中出售3,760股股票之後進行的，總收益爲41,815美元。
根據最新文件，Arcutis Biotherapeutics, Inc.高管松田正定於2024年2月5日出售5,016股普通股。這些股票的總市價爲43,828美元，於2024年1月5日通過Arcutis Biotherapeutics的限制性股票背心收購。該交易是在松田在過去三個月中出售3,760股股票之後進行的，總收益爲41,815美元。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。